Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective.

Sidorenkov G, Nagel J, Meijer C, Duker JJ, Groen HJM, Halmos GB, Oonk MHM, Oostergo RJ, van der Vegt B, Witjes MJH, Nijland M, Havenga K, Maduro JH, Gietema JA, de Bock GH.

J Transl Med. 2019 Nov 14;17(1):374. doi: 10.1186/s12967-019-2122-x.

PMID:
31727094
2.

International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.

Olivotto IA, Link E, Phillips C, Whelan TJ, Bryant G, Kunkler IH, Westenberg AH, Purohit K, Ahern V, Graham PH, Akra M, McArdle O, Ludbrook JJ, Harvey JA, Maduro JH, Kirkove C, Gruber G, Martin JD, Campbell ID, Delaney GP, Chua BH; BIG 03-07/TROG 07.01 trial investigators.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33017-8. doi: 10.1016/j.radonc.2019.07.024. [Epub ahead of print]

PMID:
31431385
3.

Evaluating the benefit of PBS vs. VMAT dose distributions in terms of dosimetric sparing and robustness against inter-fraction anatomical changes for pediatric abdominal tumors.

Guerreiro F, Zachiu C, Seravalli E, Ribeiro CO, Janssens GO, Ries M, de Senneville BD, Maduro JH, Brouwer CL, Korevaar EW, Knopf AC, Raaymakers BW.

Radiother Oncol. 2019 Sep;138:158-165. doi: 10.1016/j.radonc.2019.06.025. Epub 2019 Jul 11.

PMID:
31302390
4.

Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.

Teepen JC, Kremer LC, van der Heiden-van der Loo M, Tissing WJ, van der Pal HJ, van den Heuvel-Eibrink MM, Loonen JJ, Louwerens M, Versluys B, van Dulmen-den Broeder E, Visser O, Maduro JH, van Leeuwen FE, Ronckers CM; DCOG-LATER Study Group.

Cancer Causes Control. 2019 Sep;30(9):909-922. doi: 10.1007/s10552-019-01204-z. Epub 2019 Jul 12.

PMID:
31300947
5.

[Correspondence between primary and secondary healthcare providers about patients with cancer; how can it be improved?]

Stegmann ME, Meijer JM, Nuver J, Havenga K, Hiltermann TJN, Maduro JH, Berendsen AJ.

Ned Tijdschr Geneeskd. 2019 May 31;163. pii: D3616. Dutch.

PMID:
31187961
6.

Development and evaluation of an auto-segmentation tool for the left anterior descending coronary artery of breast cancer patients based on anatomical landmarks.

van den Bogaard VAB, van Dijk LV, Vliegenthart R, Sijtsema NM, Langendijk JA, Maduro JH, Crijns APG.

Radiother Oncol. 2019 Jul;136:15-20. doi: 10.1016/j.radonc.2019.03.013. Epub 2019 Apr 4.

PMID:
31015118
7.

Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer.

Kok JL, Teepen JC, van der Pal HJ, van Leeuwen FE, Tissing WJE, Neggers SJCMM, Loonen JJ, Louwerens M, Versluys B, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Jaspers MMW, van Santen HM, van der Heiden-van der Loo M, Janssens GO, Maduro JH, Bruggink AH, Jongmans MC, Kremer LCM, Ronckers CM; DCOG-LATER Study Group.

JAMA Oncol. 2019 May 1;5(5):671-680. doi: 10.1001/jamaoncol.2018.6862.

PMID:
30920605
8.

Correspondence between primary and secondary care about patients with cancer: a Delphi consensus study.

Stegmann ME, Homburg TM, Meijer JM, Nuver J, Havenga K, Hiltermann TJN, Maduro JH, Schuling J, Brandenbarg D, Berendsen AJ.

Support Care Cancer. 2019 Nov;27(11):4199-4205. doi: 10.1007/s00520-019-04712-5. Epub 2019 Mar 1.

9.

Cardiac Function After Radiation Therapy for Breast Cancer.

van den Bogaard VAB, van Luijk P, Hummel YM, van der Meer P, Schuit E, Boerman LM, Maass SWMC, Nauta JF, Steggink LC, Gietema JA, de Bock GH, Berendsen AJ, Smit WGJM, Sijtsema NM, Kierkels RGJ, Langendijk JA, Crijns APG, Maduro JH.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):392-400. doi: 10.1016/j.ijrobp.2019.02.003. Epub 2019 Feb 11.

PMID:
30763659
10.

Feasibility of MRI-only photon and proton dose calculations for pediatric patients with abdominal tumors.

Guerreiro F, Koivula L, Seravalli E, Janssens GO, Maduro JH, Brouwer CL, Korevaar EW, Knopf AC, Korhonen J, Raaymakers BW.

Phys Med Biol. 2019 Feb 25;64(5):055010. doi: 10.1088/1361-6560/ab0095.

PMID:
30669135
11.

Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors.

Schreuder K, Maduro JH, Spronk PER, Bijker N, Poortmans PMP, van Dalen T, Struikmans H, Siesling S.

Clin Oncol (R Coll Radiol). 2019 Apr;31(4):250-259. doi: 10.1016/j.clon.2018.11.033. Epub 2018 Dec 8.

PMID:
30538083
12.

Correspondence between primary and secondary care about patients with cancer: A qualitative mixed-methods analysis.

Stegmann ME, Meijer JM, Nuver J, Havenga K, Hiltermann TJN, Maduro JH, Schuling J, Berendsen AJ.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12903. doi: 10.1111/ecc.12903. Epub 2018 Aug 23.

13.

Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.

Kok JL, Teepen JC, van Leeuwen FE, Tissing WJE, Neggers SJCMM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, van der Heiden-van der Loo M, Aleman BMP, Daniels LA, Haasbeek CJA, Hoeben B, Janssens GO, Maduro JH, Oldenburger F, van Rij C, Tersteeg RJHA, Hauptmann M; DCOG-LATER Study Group, Kremer LCM, Ronckers CM.

Neuro Oncol. 2019 Feb 19;21(3):392-403. doi: 10.1093/neuonc/noy124.

PMID:
30099534
14.

Discrepancies Between Surgical Oncologists and Plastic Surgeons in Patient Information Provision and Personal Opinions Towards Immediate Breast Reconstruction.

van Bommel ACM, Schreuder K, Veenstra RK, de Ligt KM, Vrancken Peeters MTFD, Maduro JH, Siesling S, Mureau MAM.

Ann Plast Surg. 2018 Oct;81(4):383-388. doi: 10.1097/SAP.0000000000001572.

PMID:
30067531
15.

Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.

Brouwers PJAM, van Werkhoven E, Bartelink H, Fourquet A, Lemanski C, van Loon J, Maduro JH, Russell NS, Scheijmans LJEE, Schinagl DAX, Westenberg AH, Poortmans P, Boersma LJ; Young Boost Trial research group.

Radiother Oncol. 2018 Sep;128(3):434-441. doi: 10.1016/j.radonc.2018.06.020. Epub 2018 Jul 3.

PMID:
29980320
16.

The effect of being informed on receiving immediate breast reconstruction in breast cancer patients.

de Ligt KM, van Bommel ACM, Schreuder K, Maduro JH, Vrancken Peeters MTFD, Mureau MAM, Siesling S; NABON Breast Cancer Audit Working Group.

Eur J Surg Oncol. 2018 May;44(5):717-724. doi: 10.1016/j.ejso.2018.01.226. Epub 2018 Feb 2.

PMID:
29452858
17.

Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy?

Roos CTG, van den Bogaard VAB, Greuter MJW, Vliegenthart R, Schuit E, Langendijk JA, van der Schaaf A, Crijns APG, Maduro JH.

Radiother Oncol. 2018 Jan;126(1):170-176. doi: 10.1016/j.radonc.2017.10.009. Epub 2017 Oct 28.

PMID:
29089148
18.

Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study.

Boerman LM, Maass SWMC, van der Meer P, Gietema JA, Maduro JH, Hummel YM, Berger MY, de Bock GH, Berendsen AJ.

Eur J Cancer. 2017 Aug;81:56-65. doi: 10.1016/j.ejca.2017.05.013. Epub 2017 Jun 8.

PMID:
28601706
19.

The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.

van Maaren MC, Bretveld RW, Jobsen JJ, Veenstra RK, Groothuis-Oudshoorn CG, Struikmans H, Maduro JH, Strobbe LJ, Poortmans PM, Siesling S.

Br J Cancer. 2017 Jul 11;117(2):179-188. doi: 10.1038/bjc.2017.159. Epub 2017 Jun 6.

20.

Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands.

Schreuder K, van Bommel ACM, de Ligt KM, Maduro JH, Vrancken Peeters MTFD, Mureau MAM, Siesling S.

Breast. 2017 Aug;34:96-102. doi: 10.1016/j.breast.2017.05.011. Epub 2017 May 25.

PMID:
28552797
21.

Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures.

van den Bogaard VA, Ta BD, van der Schaaf A, Bouma AB, Middag AM, Bantema-Joppe EJ, van Dijk LV, van Dijk-Peters FB, Marteijn LA, de Bock GH, Burgerhof JG, Gietema JA, Langendijk JA, Maduro JH, Crijns AP.

J Clin Oncol. 2017 Apr 10;35(11):1171-1178. doi: 10.1200/JCO.2016.69.8480. Epub 2017 Jan 17. Erratum in: J Clin Oncol. 2017 Nov 10;35(32):3736.

22.

Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands.

van Bommel AC, Mureau MA, Schreuder K, van Dalen T, Vrancken Peeters MT, Schrieks M, Maduro JH, Siesling S.

J Plast Reconstr Aesthet Surg. 2017 Feb;70(2):215-221. doi: 10.1016/j.bjps.2016.10.022. Epub 2016 Nov 11.

PMID:
27993547
23.

Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit.

van Bommel AC, Spronk PE, Vrancken Peeters MT, Jager A, Lobbes M, Maduro JH, Mureau MA, Schreuder K, Smorenburg CH, Verloop J, Westenend PJ, Wouters MW, Siesling S, Tjan-Heijnen VC, van Dalen T; NABON Breast Cancer Audit.

J Surg Oncol. 2017 Mar;115(3):243-249. doi: 10.1002/jso.24516. Epub 2016 Nov 25.

PMID:
27885679
24.

Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction model.

Hammer C, Maduro JH, Bantema-Joppe EJ, van der Schaaf A, van der Laan HP, Langendijk JA, Crijns AP.

Radiother Oncol. 2017 Jan;122(1):45-49. doi: 10.1016/j.radonc.2016.10.006. Epub 2016 Oct 25.

PMID:
27793444
25.

Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.

Brouwers PJ, van Werkhoven E, Bartelink H, Fourquet A, Lemanski C, van Loon J, Maduro JH, Russell NS, Scheijmans LJ, Schinagl DA, Westenberg AH, Poortmans P, Boersma LJ; Young Boost Trial research group.

Radiother Oncol. 2016 Jul;120(1):107-13. doi: 10.1016/j.radonc.2016.04.017. Epub 2016 May 28.

PMID:
27247055
26.

Quantification of renal and diaphragmatic interfractional motion in pediatric image-guided radiation therapy: A multicenter study.

Huijskens SC, van Dijk IW, de Jong R, Visser J, Fajardo RD, Ronckers CM, Janssens GO, Maduro JH, Rasch CR, Alderliesten T, Bel A.

Radiother Oncol. 2015 Dec;117(3):425-31. doi: 10.1016/j.radonc.2015.09.020. Epub 2015 Sep 30.

PMID:
26433905
27.

Factors influencing time between surgery and radiotherapy: A population based study of breast cancer patients.

Katik S, Gort M, Jobsen JJ, Maduro JH, Struikmans H, Siesling S.

Breast. 2015 Aug;24(4):468-75. doi: 10.1016/j.breast.2015.04.005. Epub 2015 Apr 29.

PMID:
25933729
28.

The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy.

Bantema-Joppe EJ, de Bock GH, Woltman-van Iersel M, Busz DM, Ranchor AV, Langendijk JA, Maduro JH, van den Heuvel ER.

Br J Cancer. 2015 Feb 17;112(4):636-43. doi: 10.1038/bjc.2014.632. Epub 2015 Jan 20.

29.

Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients.

Mast ME, Vredeveld EJ, Credoe HM, van Egmond J, Heijenbrok MW, Hug EB, Kalk P, van Kempen-Harteveld LM, Korevaar EW, van der Laan HP, Langendijk JA, Rozema HJ, Petoukhova AL, Schippers JM, Struikmans H, Maduro JH.

Breast Cancer Res Treat. 2014 Nov;148(1):33-9. doi: 10.1007/s10549-014-3149-6. Epub 2014 Oct 1.

30.

Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands.

Siesling S, Tjan-Heijnen VC, de Roos M, Snel Y, van Dalen T, Wouters MW, Struikmans H, van der Hoeven JJ, Maduro JH, Visser O.

Breast Cancer Res Treat. 2014 Aug;147(1):177-84. doi: 10.1007/s10549-014-3075-7. Epub 2014 Aug 9.

PMID:
25106659
31.

Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population.

Boerman LM, Berendsen AJ, van der Meer P, Maduro JH, Berger MY, de Bock GH.

Support Care Cancer. 2014 Jul;22(7):1949-58. doi: 10.1007/s00520-014-2156-9. Epub 2014 Mar 2.

PMID:
24584711
32.

Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence.

Bantema-Joppe EJ, Vredeveld EJ, de Bock GH, Busz DM, Woltman-van Iersel M, Dolsma WV, van der Laan HP, Langendijk JA, Maduro JH.

Radiother Oncol. 2013 Aug;108(2):269-72. doi: 10.1016/j.radonc.2013.08.037. Epub 2013 Sep 19.

PMID:
24055289
33.

Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients.

Bantema-Joppe EJ, van den Heuvel ER, de Munck L, de Bock GH, Smit WG, Timmer PR, Dolsma WV, Jansen L, Schröder CP, Siesling S, Langendijk JA, Maduro JH.

Breast Cancer Res Treat. 2013 Aug;140(3):577-85. doi: 10.1007/s10549-013-2650-7. Epub 2013 Aug 3.

PMID:
23912958
34.

Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.

Bantema-Joppe EJ, Schilstra C, de Bock GH, Dolsma WV, Busz DM, Langendijk JA, Maduro JH.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e471-7. doi: 10.1016/j.ijrobp.2012.01.050. Epub 2012 Apr 10.

35.

Electronic portal images (EPIs) based position verification for the breast simultaneous integrated boost (SIB) technique.

Sijtsema NM, van Dijk-Peters FB, Langendijk JA, Maduro JH, van 't Veld AA.

Radiother Oncol. 2012 Jan;102(1):108-14. doi: 10.1016/j.radonc.2011.10.007. Epub 2011 Nov 16.

36.

Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival.

Bantema-Joppe EJ, van der Laan HP, de Bock GH, Wijsman R, Dolsma WV, Busz DM, Langendijk JA, Maduro JH.

Radiother Oncol. 2011 Aug;100(2):215-20. doi: 10.1016/j.radonc.2011.05.027. Epub 2011 Jun 2.

37.

Early-stage young breast cancer patients: impact of local treatment on survival.

Bantema-Joppe EJ, de Munck L, Visser O, Willemse PH, Langendijk JA, Siesling S, Maduro JH.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e553-9. doi: 10.1016/j.ijrobp.2011.02.060. Epub 2011 Sep 9.

38.

Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancer.

Maduro JH, den Dekker HA, Pras E, de Vries EG, van der Zee AG, Klokman WJ, Reyners AK, van Leeuwen FE, Langendijk JA, de Bock GH, Gietema JA.

Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1337-44. doi: 10.1016/j.ijrobp.2009.09.061. Epub 2010 Mar 29.

PMID:
20350792
39.

Limited benefit of inversely optimised intensity modulation in breast conserving radiotherapy with simultaneously integrated boost.

van der Laan HP, Dolsma WV, Schilstra C, Korevaar EW, de Bock GH, Maduro JH, Langendijk JA.

Radiother Oncol. 2010 Mar;94(3):307-12. doi: 10.1016/j.radonc.2010.01.024. Epub 2010 Feb 18.

PMID:
20171751
40.

Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation.

van der Laan HP, Korevaar EW, Dolsma WV, Maduro JH, Langendijk JA.

Radiother Oncol. 2010 Feb;94(2):235-40. doi: 10.1016/j.radonc.2009.12.015. Epub 2010 Jan 18.

PMID:
20080312
41.

Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.

Noordhuis MG, Eijsink JJ, Ten Hoor KA, Roossink F, Hollema H, Arts HJ, Pras E, Maduro JH, Reyners AK, de Bock GH, Wisman GB, Schuuring E, van der Zee AG.

Clin Cancer Res. 2009 Dec 1;15(23):7389-97. doi: 10.1158/1078-0432.CCR-09-1149. Epub 2009 Nov 17.

42.

The prognostic value of TRAIL and its death receptors in cervical cancer.

Maduro JH, Noordhuis MG, ten Hoor KA, Pras E, Arts HJ, Eijsink JJ, Hollema H, Mom CH, de Jong S, de Vries EG, de Bock GH, van der Zee AG.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):203-11. doi: 10.1016/j.ijrobp.2009.03.071.

PMID:
19695437
43.

Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.

Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):543-52. doi: 10.1016/j.ijrobp.2008.06.1902.

PMID:
18793956
44.

Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy.

van der Laan HP, Dolsma WV, Maduro JH, Korevaar EW, Langendijk JA.

Radiat Oncol. 2008 Jan 31;3:6. doi: 10.1186/1748-717X-3-6.

45.

Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy.

van der Laan HP, Dolsma WV, Maduro JH, Korevaar EW, Hollander M, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1018-23. Epub 2007 Mar 26.

PMID:
17379440
46.

Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.

Hougardy BM, Maduro JH, van der Zee AG, de Groot DJ, van den Heuvel FA, de Vries EG, de Jong S.

Int J Cancer. 2006 Apr 15;118(8):1892-900.

47.

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.

Hougardy BM, Maduro JH, van der Zee AG, Willemse PH, de Jong S, de Vries EG.

Lancet Oncol. 2005 Aug;6(8):589-98. Review.

PMID:
16054570
48.

The role of antibiotic prophylaxis in prevention of wound infection after Lichtenstein open mesh repair of primary inguinal hernia: a multicenter double-blind randomized controlled trial.

Aufenacker TJ, van Geldere D, van Mesdag T, Bossers AN, Dekker B, Scheijde E, van Nieuwenhuizen R, Hiemstra E, Maduro JH, Juttmann JW, Hofstede D, van Der Linden CT, Gouma DJ, Simons MP.

Ann Surg. 2004 Dec;240(6):955-60; discussion 960-1.

49.

Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer.

Maduro JH, Pras E, Willemse PH, de Vries EG.

Cancer Treat Rev. 2003 Dec;29(6):471-88. Review.

PMID:
14585258
50.

Treatment of cervical cancer.

Willemse PH, de Vries EG, Pras E, Maduro JH.

Lancet. 2002 Jan 26;359(9303):357-8. No abstract available.

PMID:
11830237

Supplemental Content

Loading ...
Support Center